Showing results (191-200 of 239) with videos related to

Sort By:
Pageof 24
Blood|May 29, 2000
Modulation of factor VII levels by intron 7 polymorphisms: population and in vitro studiesM Pinotti, R Toso, D Girelli, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 8, 2013
The radiosensitization effect of titanate nanotubes as a new tool in radiation therapy for glioblastoma: a proof-of-conceptC Mirjolet, A L Papa, G Créhange, et al.
Injury|July 1, 2008
Perceived value of trauma autopsy among trauma medical directors and coronersSteven Santanello, Dorothy Dean, John R Hayes, et al.
Applied and Environmental Microbiology|December 15, 2015
An Interspecies Signaling System Mediated by Fusaric Acid Has Parallel Effects on Antifungal Metabolite Production by Pseudomonas protegens Strain Pf-5 and Antibiosis of Fusarium sppMaria Carolina Quecine, Teresa A Kidarsa, Neal C Goebel, et al.
Journal of Human Stress|September 1, 1982
Propranolol medication among coronary patients: relationship to type A behavior and cardiovascular responseD S Krantz, L A Durel, J E Davia, et al.
Journal of the American Geriatrics Society|July 1, 1992
Effects of advancing age on the efficacy and side effects of antiarrhythmic drugs in post-myocardial infarction patients with ventricular arrhythmias. The CAST InvestigatorsT Akiyama, Y Pawitan, W B Campbell, et al.
Tumori|August 9, 2003
[New thrombophilia markers in digestive tract neoplasia]V Parisi, F Capasso, L Pudore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 27, 2003
Pharmacokinetics and pharmacodynamics of nelfinavir administered twice or thrice daily to human immunodeficiency virus type 1-infected childrenG Gatti, G Castelli-Gattinara, M Cruciani, et al.
Journal of Neurotrauma|January 28, 2005
A novel marker for traumatic brain injury: CSF alphaII-spectrin breakdown product levelsN C Ringger, B E O'Steen, J G Brabham, et al.
Molecular Pharmacology|January 15, 2021
CRISPR/Cas9 Genome Editing of the Human Topoisomerase II<i>α</i> Intron 19 5' Splice Site Circumvents Etoposide Resistance in Human Leukemia K562 CellsVictor A Hernandez, Jessika Carvajal-Moreno, Jonathan L Papa, et al.
Pageof 24